<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6819294/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>The reported cases of acyclovir/valacyclovir neurotoxicity in the literature</p>
 </caption>
 <thead align="center">
  <tr>
   <td rowspan="2" align="left" colspan="1" id="0-0-B-a">
    <b>Author</b>
   </td>
   <td rowspan="2" colspan="1" id="0-1-B-a">
    <b>Year of publication</b>
   </td>
   <td rowspan="1" colspan="1" id="0-2-.">
    <b>Patient</b>
   </td>
   <td rowspan="2" colspan="1" id="0-3-B-a">
    <b>Stage of CKD</b>
   </td>
   <td rowspan="2" colspan="1" id="0-4-B-a">
    <b>Renal replacement manner</b>
   </td>
   <td rowspan="2" colspan="1" id="0-5-B-a">
    <b>Dosage (mg/d)</b>
   </td>
   <td rowspan="2" colspan="1" id="0-6-B-a">
    <b>Duration of antiviral treatment</b>
   </td>
   <td rowspan="2" colspan="1" id="0-7-B-a">
    <b>Concomi-tant medication</b>
   </td>
   <td rowspan="2" colspan="1" id="0-8-B-a">
    <b>Neuropsy-chiatric symptoms</b>
   </td>
   <td rowspan="2" colspan="1" id="0-9-B-a">
    <b>Outcome</b>
   </td>
  </tr>
  <tr>
   <td rowspan="1" colspan="1" id="1-2-.">
    <b>sex/age</b>
   </td>
  </tr>
 </thead>
 <tbody align="center">
  <tr>
   <td align="left" rowspan="1" colspan="1">Pipili et al[ 
    <a rid="B18" ref-type="bibr">18</a>] 
   </td>
   <td rowspan="1" colspan="1">2013</td>
   <td rowspan="1" colspan="1">Female/72</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">PD</td>
   <td rowspan="1" colspan="1">Valacyclovir tablets 3 g daily for 3 d</td>
   <td rowspan="1" colspan="1">3 d</td>
   <td rowspan="1" colspan="1">Nifedipine, irbesartan, cinacalcet, atorvastatin, alfacalcidol</td>
   <td rowspan="1" colspan="1">Confusion and visual hallucinations</td>
   <td rowspan="1" colspan="1">3 d, restored after PD 6 × 2 L per day</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Chaudhari et al[ 
    <a rid="B16" ref-type="bibr">16</a>] 
   </td>
   <td rowspan="1" colspan="1">2014</td>
   <td rowspan="1" colspan="1">Male/66</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">PD</td>
   <td rowspan="1" colspan="1">Oral valacyclovir 1000 mg daily for 7 d</td>
   <td rowspan="1" colspan="1">7 d</td>
   <td rowspan="1" colspan="1">Simvastatin, metoprolol, sevelamer, furosemide, and glimepiride</td>
   <td rowspan="1" colspan="1">Hallucination, insomnia, and photosensi-tivity</td>
   <td rowspan="1" colspan="1">7 d, improved after regular regimen and hydration</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Asahi et al[ 
    <a rid="B17" ref-type="bibr">17</a>] 
   </td>
   <td rowspan="1" colspan="1">2009</td>
   <td rowspan="1" colspan="1">Female/78</td>
   <td rowspan="1" colspan="1">Without previous renal failure</td>
   <td rowspan="1" colspan="1">NO</td>
   <td rowspan="1" colspan="1">Valacyclovir 3000 mg/d</td>
   <td rowspan="1" colspan="1">6 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Unconsciou-sness</td>
   <td rowspan="1" colspan="1">5 d, recovered 14 d later</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Asahi et al[ 
    <a rid="B17" ref-type="bibr">17</a>] 
   </td>
   <td rowspan="1" colspan="1">2009</td>
   <td rowspan="1" colspan="1">Male/73</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">Hemodialysis</td>
   <td rowspan="1" colspan="1">Valacyclovir 3000 mg/d</td>
   <td rowspan="1" colspan="1">2 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Confusion, hallucination</td>
   <td rowspan="1" colspan="1">2 d, completely recovered 3 d later</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Singh et al[ 
    <a rid="B19" ref-type="bibr">19</a>] 
   </td>
   <td rowspan="1" colspan="1">2014</td>
   <td rowspan="1" colspan="1">Female/58</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">HD</td>
   <td rowspan="1" colspan="1">Valacyclovir 500 mg/d</td>
   <td rowspan="1" colspan="1">2 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Altered sensorium, irritability, drowsiness, confusion</td>
   <td rowspan="1" colspan="1">2 d, completely recovered 5 d later</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Kambham-pati et al[ 
    <a rid="B20" ref-type="bibr">20</a>] 
   </td>
   <td rowspan="1" colspan="1">2011</td>
   <td rowspan="1" colspan="1">Female/49</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">Maintenance hemodialysis</td>
   <td rowspan="1" colspan="1">Valacyclovir 1000 mg three times a day</td>
   <td rowspan="1" colspan="1">2 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Disoriented, confused, agitated, hallucinating, delirious, incoherent</td>
   <td rowspan="1" colspan="1">1 d, 4000 mg, completely recovered after second session of hemodialysis</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Prasad et al[ 
    <a rid="B14" ref-type="bibr">14</a>] 
   </td>
   <td rowspan="1" colspan="1">2017</td>
   <td rowspan="1" colspan="1">Female/57</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">PD</td>
   <td rowspan="1" colspan="1">1000 mg three times per day of valacyclovir</td>
   <td rowspan="1" colspan="1">3 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Confusion and altered sensorium</td>
   <td rowspan="1" colspan="1">1 day, completely recovered 24 h later</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Izzedine et al[ 
    <a rid="B21" ref-type="bibr">21</a>] 
   </td>
   <td rowspan="1" colspan="1">2001</td>
   <td rowspan="1" colspan="1">Female/60</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">PD</td>
   <td rowspan="1" colspan="1">Valacyclovir 500 mg daily</td>
   <td rowspan="1" colspan="1">Reduced 500 mg of valacyclovir every 2 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Disorientated with ocular and auditory hallucinations and loss of decorum without torpor or coma.</td>
   <td rowspan="1" colspan="1">3 d, recovered 48 h later</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Strumia et al[ 
    <a rid="B22" ref-type="bibr">22</a>] 
   </td>
   <td rowspan="1" colspan="1">2004</td>
   <td rowspan="1" colspan="1">Male/81</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">Hemodialysis</td>
   <td rowspan="1" colspan="1">Oral valacyclovir 1000 mg every 8 h then intravenous acyclovir in full dosage</td>
   <td rowspan="1" colspan="1">3 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Visual hallucination, confusion and disorientation</td>
   <td rowspan="1" colspan="1">3 daysd completely recovered 6 d later</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Linssen-Schuurmans et al[ 
    <a rid="B23" ref-type="bibr">23</a>] 
   </td>
   <td rowspan="1" colspan="1">1998</td>
   <td rowspan="1" colspan="1">Male/58</td>
   <td rowspan="1" colspan="1">CKD</td>
   <td rowspan="1" colspan="1">Intermittent hemodialysis twice a week</td>
   <td rowspan="1" colspan="1">Valacyclovir 3 g/d</td>
   <td rowspan="1" colspan="1">2 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Dizziness, hallucinations, loss of decorum, disoriented, slurred speech</td>
   <td rowspan="1" colspan="1">1 d, complete recovery</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Takayanagi et al[ 
    <a rid="B24" ref-type="bibr">24</a>] 
   </td>
   <td rowspan="1" colspan="1">2010</td>
   <td rowspan="1" colspan="1">Male/67</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">PD</td>
   <td rowspan="1" colspan="1">Valacyclovir, 1 g/d</td>
   <td rowspan="1" colspan="1">5 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Hallucina-tions</td>
   <td rowspan="1" colspan="1">7 d, complete recovery</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Sadjadi et al[ 
    <a rid="B25" ref-type="bibr">25</a>] 
   </td>
   <td rowspan="1" colspan="1">2018</td>
   <td rowspan="1" colspan="1">Male/80</td>
   <td rowspan="1" colspan="1">ESRD</td>
   <td rowspan="1" colspan="1">PD</td>
   <td rowspan="1" colspan="1">Acyclovir 5 mg/kg intravenously, followed by oral acyclobir 400 mg/d</td>
   <td rowspan="1" colspan="1">3 d</td>
   <td rowspan="1" colspan="1">Not mentioned</td>
   <td rowspan="1" colspan="1">Confusion, delusion, disorientation, restlessness, visual hallucinations, seizures</td>
   <td rowspan="1" colspan="1">2 d, complete recovery</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>CKD: Chronic kidney disease; ESRD: End-stage renal disease; PD: Peritoneal dialysis.</p>
  </p>
 </tfoot>
</table>
